These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8892090)

  • 1. Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV-I infection of T cells.
    Scholz C; Hafler DA; Höllsberg P
    J Neurosci Res; 1996 Sep; 45(6):786-94. PubMed ID: 8892090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
    Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
    J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
    Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
    J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.
    Volkman DJ; Popovic M; Gallo RC; Fauci AS
    J Immunol; 1985 Jun; 134(6):4237-43. PubMed ID: 2580910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
    Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
    J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.
    Höllsberg P; Wucherpfennig KW; Ausubel LJ; Calvo V; Bierer BE; Hafler DA
    J Immunol; 1992 May; 148(10):3256-63. PubMed ID: 1374452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
    Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
    J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
    Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I-induced T-cell activation.
    Buckle GJ; Hafler DA; Höllsberg P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S107-13. PubMed ID: 8797712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
    Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
    J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in T cell phenotype and activated MAPKs are correlated to impaired cellular responses to antigens and glucocorticoids during HTLV-I infection.
    Pillat MM; Correa BL; da Rocha CF; Müller GC; Lopes RP; Lampert SS; Teixeira AL; Menna-Barreto M; Bauer ME
    J Neuroimmunol; 2009 Nov; 216(1-2):76-84. PubMed ID: 19766325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
    Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
    Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules.
    Knolle PA; Uhrig A; Hegenbarth S; Löser E; Schmitt E; Gerken G; Lohse AW
    Clin Exp Immunol; 1998 Dec; 114(3):427-33. PubMed ID: 9844054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation.
    Matyszak MK; Denis-Donini S; Citterio S; Longhi R; Granucci F; Ricciardi-Castagnoli P
    Eur J Immunol; 1999 Oct; 29(10):3063-76. PubMed ID: 10540317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
    Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
    Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.